1.65
price up icon0.61%   0.01
after-market Dopo l'orario di chiusura: 1.65
loading
Precedente Chiudi:
$1.64
Aprire:
$1.63
Volume 24 ore:
91,310
Relative Volume:
0.46
Capitalizzazione di mercato:
$83.98M
Reddito:
-
Utile/perdita netta:
$-68.96M
Rapporto P/E:
-1.0123
EPS:
-1.63
Flusso di cassa netto:
$-56.62M
1 W Prestazione:
+0.00%
1M Prestazione:
+7.84%
6M Prestazione:
-17.09%
1 anno Prestazione:
-13.61%
Intervallo 1D:
Value
$1.62
$1.66
Intervallo di 1 settimana:
Value
$1.59
$1.66
Portata 52W:
Value
$1.40
$3.47

Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile

Name
Nome
Pmv Pharmaceuticals Inc
Name
Telefono
(609) 642-6664
Name
Indirizzo
ONE RESEARCH WAY, PRINCETON
Name
Dipendente
63
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
PMVP's Discussions on Twitter

Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2022-03-02 Aggiornamento Oppenheimer Perform → Outperform
2021-09-22 Aggiornamento Goldman Neutral → Buy
2021-08-19 Iniziato Oppenheimer Perform
2021-08-02 Iniziato Guggenheim Buy
2021-07-29 Iniziato H.C. Wainwright Buy
2020-10-20 Iniziato BofA Securities Buy
2020-10-20 Iniziato Cowen Outperform
2020-10-20 Iniziato Evercore ISI Outperform
2020-10-20 Iniziato Goldman Neutral
Mostra tutto

Pmv Pharmaceuticals Inc Borsa (PMVP) Ultime notizie

pulisher
Oct 28, 2024

Rezatapopt Monotherapy Remains Under Study Following Discontinuation of Combination Cohort in TP53+ Solid Tumors - OncLive

Oct 28, 2024
pulisher
Oct 23, 2024

US Penny Stocks To Consider In October 2024 - Simply Wall St

Oct 23, 2024
pulisher
Oct 23, 2024

PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial - GlobeNewswire

Oct 23, 2024
pulisher
Oct 16, 2024

SG Americas Securities LLC Invests $554,000 in Amicus Therapeutics, Inc. (NASDAQ:FOLD) - Defense World

Oct 16, 2024
pulisher
Oct 08, 2024

SG Americas Securities LLC Grows Stake in Stellantis (NYSE:STLA) - Defense World

Oct 08, 2024
pulisher
Oct 07, 2024

ELVN-001 Appears Safe and Effective in Relapsed/Refractory CML - OncLive

Oct 07, 2024
pulisher
Oct 02, 2024

Envestnet Asset Management Inc. Sells 2,501 Shares of Juniper Networks, Inc. (NYSE:JNPR) - Defense World

Oct 02, 2024
pulisher
Sep 29, 2024

Point72 Asia Singapore Pte. Ltd. Takes $101,000 Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Sep 29, 2024
pulisher
Sep 26, 2024

PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance

Sep 26, 2024
pulisher
Sep 25, 2024

PRISM MarketView Features Q&A with Dr. Michael Chancellor: - GlobeNewswire

Sep 25, 2024
pulisher
Sep 23, 2024

Pawan Singh sharing his grief with Mata Rani, asking questions from his mind, Pawan Singh sharing his grief with Mata Rani, asking questions from his mind - AnyTV News

Sep 23, 2024
pulisher
Sep 23, 2024

Small Cap Stocks: Plexus, Parkmead, Proton Motor - The Armchair Trader

Sep 23, 2024
pulisher
Sep 23, 2024

Stock market news: PC Jeweller shares hit 5% upper circuit- Check Details - MSN

Sep 23, 2024
pulisher
Sep 22, 2024

Vanguard Personalized Indexing Management LLC Increases Position in PDD Holdings Inc. (NASDAQ:PDD) - Defense World

Sep 22, 2024
pulisher
Sep 21, 2024

2 ASX shares I can’t ignore: PME and SOL - Rask Media

Sep 21, 2024
pulisher
Sep 21, 2024

40% women with PCOD may get diabetes: Experts - The Times of India

Sep 21, 2024
pulisher
Sep 21, 2024

Parvin Dabas, Pro Panja League Co-Founder, In ICU After Road Accident - Pratidin Time

Sep 21, 2024
pulisher
Sep 21, 2024

Agency News | ⚡Pro Panja League Co-Founder and Actor Parvin Dabas Admitted to ICU Following Car Accident - LatestLY

Sep 21, 2024
pulisher
Sep 19, 2024

Should PME shares be on your watchlist? - Rask Media

Sep 19, 2024
pulisher
Sep 19, 2024

Power Mech Shares Gain on Securing Orders Worth Rs 865 Crore - EquityPandit

Sep 19, 2024
pulisher
Sep 19, 2024

Power Mech rises on Rs 865-cr order win from Vedanta's subsidiary - Business Standard

Sep 19, 2024
pulisher
Sep 18, 2024

Bowers & Wilkins Launches Px7 S2e “Ruby Red” and Px8 “Dark Forest” - HYPEBEAST

Sep 18, 2024
pulisher
Sep 18, 2024

Bowers & Wilkins adds two new colors to PX7 S2e & PX8 headphones - Gstyle magazine

Sep 18, 2024
pulisher
Sep 12, 2024

PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com Canada

Sep 12, 2024
pulisher
Sep 12, 2024

PMV Pharmaceuticals CFO sells over $4,300 in company stock By Investing.com - Investing.com Canada

Sep 12, 2024
pulisher
Sep 12, 2024

PMV Pharmaceuticals executive sells over $10k in company stock - Investing.com India

Sep 12, 2024
pulisher
Sep 12, 2024

Insider Selling: PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Insider Sells 7,218 Shares of Stock - MarketBeat

Sep 12, 2024
pulisher
Sep 12, 2024

PMV Pharmaceuticals CFO sells over $4,300 in company stock - Investing.com India

Sep 12, 2024
pulisher
Sep 12, 2024

Wharton San Diego Presents: The Future of Biotechnology in San Diego - Procopio

Sep 12, 2024
pulisher
Sep 06, 2024

NCCN Adds Denileukin Diftitox to CTCL Clinical Practice Guidelines in Oncology - OncLive

Sep 06, 2024
pulisher
Sep 05, 2024

Dr Koff on the Role of Covalent BTK Inhibitors and Pirtobrutinib in MCL - OncLive

Sep 05, 2024
pulisher
Aug 28, 2024

Closing Figures: PMV Pharmaceuticals Inc (PMVP)’s Negative Finish at 1.58, Down -1.25 - The Dwinnex

Aug 28, 2024
pulisher
Aug 26, 2024

Assenagon Asset Management S.A. Has $401,000 Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World

Aug 26, 2024
pulisher
Aug 26, 2024

Envestnet Portfolio Solutions Inc. Buys 5,351 Shares of MBIA Inc. (NYSE:MBI) - Defense World

Aug 26, 2024
pulisher
Aug 26, 2024

Gene and Cell Therapy: Shaping the Future of Medicine - OncLive

Aug 26, 2024
pulisher
Aug 25, 2024

Assenagon Asset Management S.A. Boosts Stake in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat

Aug 25, 2024
pulisher
Aug 22, 2024

PMV Pharmaceuticals, Inc. to Post Q3 2024 Earnings of ($0.35) Per Share, HC Wainwright Forecasts (NASDAQ:PMVP) - MarketBeat

Aug 22, 2024
pulisher
Aug 20, 2024

PMV Pharmaceuticals' (PMVP) Buy Rating Reaffirmed at HC Wainwright - MarketBeat

Aug 20, 2024
pulisher
Aug 20, 2024

Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow

Aug 20, 2024
pulisher
Aug 20, 2024

Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung - StockTitan

Aug 20, 2024
pulisher
Aug 19, 2024

PMVP (PMV Pharmaceuticals) EPS (Basic) : $-0.97 (TTM As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

PMVP (PMV Pharmaceuticals) Purchase Of Investment : $-162.36 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

PMVP (PMV Pharmaceuticals) GF Value Rank : 0 (As of Aug. 19, 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

PMVP (PMV Pharmaceuticals) EV-to-Revenue : (As of Aug. 19, 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

Vanguard Group Inc. Purchases 46,804 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World

Aug 19, 2024
pulisher
Aug 14, 2024

FDA Grants Fast Track Status to AC699 for ER+/HER2–, ESR1-Mutated Breast Cancer - OncLive

Aug 14, 2024
pulisher
Aug 12, 2024

Small Clones, Outsized Consequences: The Many Faces of Clonal Hematopoiesis - OncLive

Aug 12, 2024
pulisher
Aug 10, 2024

Panasonic (OTCMKTS:PCRFY) Stock Price Crosses Below Fifty Day Moving Average of $9.36 - Defense World

Aug 10, 2024
pulisher
Aug 08, 2024

PMV Pharmaceuticals Initiates Strategic Lease Termination - TipRanks

Aug 08, 2024
pulisher
Aug 08, 2024

PMV Pharmaceuticals Reports Second Quarter 2024 Financial - GlobeNewswire

Aug 08, 2024
pulisher
Aug 08, 2024

PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial - StockTitan

Aug 08, 2024

Pmv Pharmaceuticals Inc Azioni (PMVP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Pmv Pharmaceuticals Inc Azioni (PMVP) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Carulli Michael
Chief Financial Officer
Sep 11 '24
Sale
1.50
2,891
4,347
88,395
ORBIMED ADVISORS LLC
10% Owner
Nov 22 '23
Sale
2.23
87,786
195,763
0
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):